Can chancroid sores cause scarring, especially in a patient with potential high-risk sexual behavior and possible Human Immunodeficiency Virus (HIV) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Chancroid Cause Scarring?

Yes, chancroid ulcers can cause scarring, particularly when healing is delayed or complicated, which is more likely in HIV-infected patients who experience slower healing and higher treatment failure rates.

Understanding Chancroid Ulcer Characteristics

Chancroid presents with deep, necrotizing genital ulcers that have purulent bases, ragged and undermined edges, and highly inflamed borders 1. These are not superficial lesions—they represent significant tissue destruction that disrupts the genital epithelium 2. The depth and purulent nature of these ulcers inherently carries scarring potential, especially when:

  • Healing is delayed: HIV-infected patients experience slower ulcer healing and may require prolonged therapy beyond standard regimens 3, 2
  • Multiple ulcers are present: Chancroid often presents with multiple painful ulcers rather than a single lesion 1
  • Suppurative lymphadenopathy occurs: Fluctuant buboes resolve more slowly than ulcers and may require drainage, creating additional sites for potential scarring 3

Critical Factors Affecting Scarring Risk

HIV co-infection significantly increases scarring risk because treatment failures occur more frequently and healing is substantially slower in HIV-positive patients 3, 2. Given your concern about possible HIV infection in this patient:

  • All patients with chancroid must receive immediate HIV testing at presentation 3, 2
  • Repeat HIV testing at 3 months is recommended if initial testing is negative, given the window period for seroconversion 2
  • HIV-infected patients should receive the 7-day erythromycin regimen (500 mg orally four times daily) with close follow-up rather than single-dose therapy 2

Treatment to Minimize Scarring

Immediate treatment is essential to reduce tissue destruction and scarring potential:

  • First-line options include azithromycin 1 g orally as a single dose or ceftriaxone 250 mg intramuscularly as a single dose 3
  • Single-dose therapy ensures compliance and allows treatment at first presentation, which is critical for limiting tissue damage 3
  • Symptomatic improvement should occur within 3 days, and objective improvement within 7 days 3
  • Patients must be re-examined 3-7 days after initiating therapy to assess treatment response 3

Common Pitfall to Avoid

Do not delay treatment while awaiting diagnostic confirmation, as chancroid is difficult to culture and diagnostic capabilities are often limited 1. The CDC notes that even after complete diagnostic evaluation, at least 25% of genital ulcers have no laboratory-confirmed diagnosis 1. If the patient resides in a community where H. ducreyi is prevalent and diagnostic capabilities are limited, treat empirically for both syphilis and chancroid 1.

References

Guideline

Distinguishing Syphilis Chancre from Chancroid Chancre

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chancroid Ulcers as HIV Entry Points

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Chancroid

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.